Are randomized controlled trials controlled? Patient preferences and unblind trials

被引:75
|
作者
McPherson, K [1 ]
Britton, AR
Wennberg, JE
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England
[2] Ctr Evaluat Clin Sci, Hanover, NH USA
关键词
D O I
10.1177/014107689709001205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most reliable information about treatment effects comes from randomized controlled trials (RCTs). However, the possibility of subtle interactions-for example, between treatment preferences and treatment effects-is generally subordinated in the quest for evidence about main treatment effects. If patient preferences can influence the effectiveness of treatments through poorly understood (psychological) pathways, then RCTs, particularly when unblinded, may wrongly attribute effects solely to a treatment's physiological/pharmacological properties. To interpret the RCT evidence base it is important to know whether any preference effects exist and, if so, by how much they affect outcome. Reliable measurement of these effects is difficult and will require new approaches to the conduct of trials. In view of the fanciful image with which such effects are portrayed and the uncertainties about their true nature and biological mechanisms, existing evidence is unlikely to provide sufficient justification for investment in trials. This is a Catch 22. Until an escape is found we might never know, even approximately, how much of modern medicine is attributable to psychological processes.
引用
收藏
页码:652 / 656
页数:5
相关论文
共 50 条
  • [21] Randomized controlled trials
    Marler, J
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 42 - 42
  • [22] Exploring treatment preferences facilitated recruitment to randomized controlled trials
    Mills, Nicola
    Donovan, Jenny L.
    Wade, Julia
    Hamdy, Freddie C.
    Neal, David E.
    Lane, J. Athene
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (10) : 1127 - 1136
  • [23] The impact of patient treatment preferences on the interpretation of randomised controlled trials
    McPherson, K
    Britton, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (11) : 1598 - 1602
  • [24] Patient Barriers to Enrollment in IBD Randomized Controlled Trials
    Ravikoff, Jessica
    Cole, Elisabeth B.
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S265 - S265
  • [25] Patient adherence: A blind spot of randomized controlled trials?
    Davis, M
    Rathouz, P
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 252A - 252A
  • [26] Patient preference and validity of randomized controlled trials - Reply
    King, M
    Nazareth, I
    Lampe, F
    Bower, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01): : 42 - 42
  • [27] Incorporating patient preferences into randomized trials
    Lambert, MF
    Wood, J
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (02) : 163 - 166
  • [28] Commentary: Randomized Controlled Trials
    Brennan, Murray F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (01) : XIX - XX
  • [29] RANDOMIZED CONTROLLED TRIALS - SAMPLING
    ELWOOD, PC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) : 631 - 636
  • [30] Preregistration of Randomized Controlled Trials
    Cook, Bryan G.
    Wong, Vivian C.
    Fleming, Jesse I.
    Solari, Emily J.
    RESEARCH ON SOCIAL WORK PRACTICE, 2025, 35 (03) : 277 - 286